Sign in / Join Now
ETFs & Funds
Whew! What a day. Besides closing some shorts, bought some
. Bought most of these around the same time I closed shorts.
Add a reply...
Latest StockTalks »
people get BMY breaking news and analysis by email alert.
Get email alerts on BMY »
Bristol-Myers Squibb Company
Get latest price
From other sites
Bristol-Myers Squibb Announces Dividend Increase
at TheStreet (Thu, 4:15PM)
Opdivo (nivolumab) Alone Or Combined With Yervoy (ipilimumab) Shows Encouraging Response And Survival Rates In Recurrent Small Cell Lung Cancer, From Phase 1/2 Study CheckMate -032
at TheStreet (Tue, 8:45AM)
Seattle Genetics And Bristol-Myers Squibb Highlight First Data From Phase 1/2 Study Evaluating ADCETRIS® (Brentuximab Vedotin) In Combination With Opdivo (nivolumab) In Relapsed Or Refractory Hodgkin Lymphoma At ASH Annual Meeting
at TheStreet (Mon, 7:30PM)
Encouraging Survival Observed With Opdivo (nivolumab) Plus Yervoy (ipilimumab) With Longer Follow-up In First-line Advanced Non-small Cell Lung Cancer, In Updated Phase 1b CheckMate -012 Study
at TheStreet (Mon, 5:00AM)
Bristol-Myers Squibb To Take Part At The Citi 2016 Global Healthcare Conference
at TheStreet (Nov 30, 2016)